ProPhase Labs, Inc. (PRPH)

0.596 -0.09 (-13.25%) USD  |  NASDAQ  |  Dec 24, 12:59
0.5991 0.00 (0.00%) After-Hours: 13:59
More

ProPhase Labs SG&A Expense (TTM): 21.00M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PRPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
FONAR Corp. 31.41M
XWELL, Inc. 13.00M
Veracyte, Inc. 219.38M
Insight Molecular Diagnostics, Inc. 16.12M
Exagen, Inc. 44.40M